BOSTON XO (hexafocon A), BOSTON XO2 (hexafocon B)

BOSTON XO (hexafocon A), BOSTON XO2 (hexafocon B) is an FDA 510(k)-cleared medical device (K171404) manufactured by Bausch + Lomb, Incorporated. This device is classified under the Ophthalmic specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on July 16, 2017. Regulation: 8.